Temporal Control of Gene Deletion in Sensory Ganglia Using a Tamoxifen-Inducible Advillin-CreERT2 Recombinase Mouse
Open Access
- 1 January 2011
- journal article
- Published by SAGE Publications in Molecular Pain
- Vol. 7 (1), 100
- https://doi.org/10.1186/1744-8069-7-100
Abstract
Background: Tissue-specific gene deletion has proved informative in the analysis of pain pathways. Advillin has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice using the Advillin promoter to drive a tamoxifen-inducible CreERT2 recombinase construct in order to be able to delete genes in adult animals. We used a floxed stop ROSA26LacZ reporter mouse to examine functional Cre expression, and analysed the behaviour of mice expressing Cre recombinase. Results: We used recombineering to introduce a CreERT2 cassette in place of exon 2 of the Advillin gene into a BAC clone (RPCI23-424F19) containing the 5' region of the Advillin gene. Transgenic mice were generated using pronuclear injection. The resulting AvCreERT2 transgenic mice showed a highly specific expression pattern of Cre activity after tamoxifen induction. Recombinase activity was confined to sensory neurons and no expression was found in other organs. Less than 1% of neurons showed Cre expression in the absence of tamoxifen treatment. Five-day intraperitoneal treatment with tamoxifen (2 mg per day) induced Cre recombination events in ≈90% of neurons in dorsal root and cranial ganglia. Cell counts of dorsal root ganglia (DRG) from transgenic animals with or without tamoxifen treatment showed no neuronal cell loss. Sensory neurons in culture showed ≈70% induction after 3 days treatment with tamoxifen. Behavioural tests showed no differences between wildtype, AvCreERT2 and tamoxifen-treated animals in terms of motor function, responses to light touch and noxious pressure, thermal thresholds as well as responses to inflammatory agents. Conclusions: Our results suggest that the inducible pan-DRG AvCreERT2 deleter mouse strain is a useful tool for studying the role of individual genes in adult sensory neuron function. The pain phenotype of the Cre-induced animal is normal; therefore any alterations in pain processing can be unambiguously attributed to loss of the targeted gene.Keywords
This publication has 31 references indexed in Scilit:
- Pain as a channelopathyJCI Insight, 2010
- Small RNAs Control Sodium Channel Expression, Nociceptor Excitability, and Pain ThresholdsJournal of Neuroscience, 2010
- Deletion of PIK3C3/Vps34 in sensory neurons causes rapid neurodegeneration by disrupting the endosomal but not the autophagic pathwayProceedings of the National Academy of Sciences of the United States of America, 2010
- Analyzing Somatosensory Axon Projections with the Sensory Neuron-SpecificAdvillinGeneJournal of Neuroscience, 2007
- EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processingNature Neuroscience, 2003
- Regulation of Cre Recombinase Activity by Mutated Estrogen Receptor Ligand-Binding DomainsBiochemical and Biophysical Research Communications, 1997
- Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life?Cell, 1995
- Peripheral Nervous System-specific Genes Identified by Subtractive cDNA CloningPublished by Elsevier BV ,1995
- Modification of the Randall-Selitto analgesic apparatusJournal of Pharmacy and Pharmacology, 1969
- A rotarod suitable for quantitative measurements of motor incoordination in naive miceNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968